Eileen McDonnell - Universal Health Lead Independent Director
| UHS Stock | USD 205.00 1.50 0.74% |
Director
Ms. Eileen C. McDonnell is an Independent Director of Universal Health Services, Inc., since April 1, 2013. Ms. McDonnell currently serves as Chairman and Chief Executive Officer of The Penn Mutual Life Insurance Company since her appointment in February 2011. Ms. McDonnell joined Penn Mutual in 2008 and previously served as President of the company. She was also appointed to The Penn Mutual Board of Trustees in 2010. Ms. McDonnell also serves on the Board of Janney Montgomery Scott LLC, a wholly owned subsidiary of Penn Mutual. Before joining Penn Mutual, Ms. McDonnell founded ExecMPower, a strategic planning and executive coaching consultancy. Previously, she was president of New England Financial, a whollyowned subsidiary of MetLife, and senior vice president of the Guardian Life Insurance Company. Ms. McDonnell serves as the Chairman of the Insurance Federation of Pennsylvania. She also serves on the Corporationrationrate Council of Childrens Hospital of Philadelphia and is a national advisor to Vision 2020, an initiative of Drexel University College of Medicine Institute for Womens Health and Leadership. since 2020.
| Age | 57 |
| Tenure | 4 years |
| Address | Universal Corporate Center, King of Prussia, PA, United States, 19406-0958 |
| Phone | 610 768 3300 |
| Web | https://www.uhs.com |
Universal Health Management Efficiency
The company has Return on Asset of 0.0682 % which means that on every $100 spent on assets, it made $0.0682 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1634 %, implying that it generated $0.1634 on every 100 dollars invested. Universal Health's management efficiency ratios could be used to measure how well Universal Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.06 in 2024. Return On Capital Employed is likely to drop to 0.1 in 2024. At this time, Universal Health's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 11.7 B in 2024, whereas Intangible Assets are likely to drop slightly above 73.2 M in 2024.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| William Frist | HCA Holdings | 51 | |
| Donald Correll | Encompass Health Corp | 70 | |
| John Clerico | Community Health Systems | 79 | |
| Brooke Matthews | Lifestance Health Group | N/A | |
| John Fry | Community Health Systems | 60 | |
| Elizabeth Hirsch | Community Health Systems | 67 | |
| James Ely | Select Medical Holdings | 63 | |
| Leslye Katz | Encompass Health Corp | 66 | |
| Nadja West | Tenet Healthcare | 60 | |
| Julia North | Community Health Systems | 72 | |
| Paul Diaz | DaVita HealthCare Partners | 58 | |
| Charles Holliday | HCA Holdings | 73 | |
| Tammy Romo | Tenet Healthcare | 58 | |
| William Frist | Select Medical Holdings | 69 | |
| Bryan Cressey | Select Medical Holdings | 71 | |
| Christopher Lynch | Tenet Healthcare | 63 | |
| Robert Dennis | HCA Holdings | 67 | |
| Michael Michelson | HCA Holdings | 69 | |
| Joan Herman | Encompass Health Corp | 67 | |
| Richard Fisher | Tenet Healthcare | 72 | |
| John Chidsey | Encompass Health Corp | 58 | |
Management Performance
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0682 |
Universal Health Services Leadership Team
Elected by the shareholders, the Universal Health's board of directors comprises two types of representatives: Universal Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Universal. The board's role is to monitor Universal Health's management team and ensure that shareholders' interests are well served. Universal Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Universal Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lynda Smirz, Chief VP | ||
| Elliot Sussman, Independent Director | ||
| Matthew Peterson, Executive Vice President of the company and President of Behavioral Health Division | ||
| Lawrence Gibbs, Independent Director | ||
| Geraldine Geckle, Senior Resources | ||
| Warren Nimetz, Director | ||
| Victor Radina, Senior Development | ||
| Marvin Pember, Executive Vice President, President of Acute Care Division | ||
| Eileen McDonnell, Lead Independent Director | ||
| Alan Miller, Executive Chairman, CEO, Member of Executive Committee and Member of Fin. Committee | ||
| Michael Nelson, Senior Services | ||
| Maria Singer, Independent Director | ||
| Marc Miller, President, Director and Member of Fin. Committee | ||
| Matthew Klein, Senior Counsel | ||
| Jim Clark, Senior Division | ||
| Edward Sim, Executive Division | ||
| Thomas Day, Senior Division | ||
| Maria Zangardi, Senior Officer | ||
| Steve Filton, Chief Financial Officer, Executive Vice President, Secretary |
Universal Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Universal Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0682 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 18.42 B | ||||
| Shares Outstanding | 58.71 M | ||||
| Shares Owned By Insiders | 4.25 % | ||||
| Shares Owned By Institutions | 94.02 % | ||||
| Number Of Shares Shorted | 1.53 M | ||||
| Price To Earning | 13.68 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Universal Stock Analysis
When running Universal Health's price analysis, check to measure Universal Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Health is operating at the current time. Most of Universal Health's value examination focuses on studying past and present price action to predict the probability of Universal Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Health's price. Additionally, you may evaluate how the addition of Universal Health to your portfolios can decrease your overall portfolio volatility.